Clinical Trials Directory

Trials / Completed

CompletedNCT06092853

Inflammatory Stress and Periodontal Tissue Destruction

Inflammatory Stress and Periodontal Tissue Destruction in Patients With Metabolic Syndrome and Periodontitis

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Recep Tayyip Erdogan University Training and Research Hospital · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Metabolic syndrome and periodontitis are diseases that lower the quality of life and their incidence rates are increasing. Since both of these diseases are associated with systemic inflammation and insulin resistance, they may be comorbid. The aim of this study was to evaluate the effect of interleukin-20 (IL-20) on periodontal destruction in individuals with metabolic syndrome while considering the relationship between metabolic syndrome and periodontitis. This study included a total of 80 individuals who were systemically and periodontally healthy (CG, n=20), were systemically healthy and had periodontitis (PG, n=20), had metabolic syndrome and were periodontally healthy (MG, n=20), or had both metabolic syndrome and periodontitis (MPG, n=20). Gingival crevicular fluid (GCF) and serum samples were collected from all participants for biochemical analyses.

Conditions

Interventions

TypeNameDescription
OTHERGingival crevicular fluid (GCF) and serum samplesGingival crevicular fluid (GCF) and serum samples were collected from all participants for biochemical analyses

Timeline

Start date
2022-06-06
Primary completion
2023-03-06
Completion
2023-06-06
First posted
2023-10-23
Last updated
2023-10-23

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06092853. Inclusion in this directory is not an endorsement.